<DOC>
	<DOCNO>NCT01215032</DOCNO>
	<brief_summary>Metformin medication prescribe people diabetes help body respond good insulin decrease sugar production liver . This help control body 's blood sugar level approve Food Drug Administration ( FDA ) treatment diabetes . Participant 's research study already receive androgen deprivation therapy ( ADT ) prostate cancer . ADT consider standard care prostate cancer . Changes participant 's metabolism , include change insulin blood sugar level , often see result type hormone therapy . Some study show relationship insulin prostate cancer . These study suggest insulin may signal tumor cell grow . Other study suggest people receive metformin treatment diabetes may enjoy good outcome prostate cancer similar patient treat metformin .</brief_summary>
	<brief_title>Metformin Castration-Resistant Prostate Cancer</brief_title>
	<detailed_description>- Each treatment cycle last 4 week ( 28 day ) . Participants take metformin twice day 28 day ( except first 7 day first cycle take daily . ) - The following procedure do Day 1 treatment cycle 1 , 2 , 4 , 7 10 : medical history review , performance status , physical exam , blood test . - If participant 's first compute tomography ( CT ) bone scan time screen show evidence cancer , CT bone scan repeat Day 1 treatment cycle 4 , 7 10 . - Participants research study 12 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Histologically cytologically confirm adenocarcinoma prostate History bilateral orchiectomy ongoing treatment GnRH agonist GnRH antagonist Disease progression accord PSA Working Group 2 Minimum start PSA ( Prostate Specific Antigen ) level 2.0 ng/mL Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 1 Symptomatic metastasis Receiving agent treatment prostate cancer except gonadotropin release hormone ( GnRH ) agonist antagonist within last 30 day Received investigational cancer treatment agent within last 30 day Prior treatment docetaxel History diabetes require drug therapy Current treatment metformin metformin treatment within last year History allergic reaction metformin Have uncontrolled intercurrent illness include , limited ongoing unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Serum creatinine 1.5mg/dL great Hepatic impairment Need ongoing treatment cimetidine History different malignancy except follow circumstance : Individuals history malignancy eligible diseasefree least 5 year deem investigator low risk recurrence malignancy . Individuals follow cancer eligible diagnose treat within past 5 year : basal cell squamous cell carcinoma skin</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>castration-resistant prostate cancer</keyword>
	<keyword>insulin level</keyword>
	<keyword>metformin</keyword>
</DOC>